Zoptarelin doxorubicin
Zoptarelin Doxorubicin
Zoptarelin Doxorubicin (pronunciation: zop-ta-rel-in dox-o-roo-bi-sin) is a synthetic analog of luteinizing hormone-releasing hormone (LHRH) conjugated to the anthracycline doxorubicin.
Etymology
The name "Zoptarelin" is derived from the synthetic analog of LHRH it is based on, while "Doxorubicin" is named after the anthracycline it is conjugated with.
Mechanism of Action
Zoptarelin Doxorubicin works by binding to LHRH receptors on the surface of cancer cells, allowing the doxorubicin to enter the cell and interfere with DNA replication, thus inhibiting the growth of the cancer cells.
Clinical Use
Zoptarelin Doxorubicin is primarily used in the treatment of prostate cancer, breast cancer, and certain types of gynecological cancers. It is currently in the clinical trial phase for other types of cancer.
Side Effects
Common side effects of Zoptarelin Doxorubicin include nausea, vomiting, hair loss, and fatigue. More serious side effects can include heart damage, low blood cell counts, and infections.
Related Terms
- Anthracycline
- Doxorubicin
- Luteinizing hormone-releasing hormone
- Cancer
- Prostate cancer
- Breast cancer
- Gynecological cancers
External links
- Medical encyclopedia article on Zoptarelin doxorubicin
- Wikipedia's article - Zoptarelin doxorubicin
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski